Does High-Dose Vitamin C Prevent Infection?
No, high-dose vitamin C should not be used to prevent infections in healthy individuals, as there is no evidence supporting this practice and guidelines explicitly recommend against antioxidant monotherapy without proven deficiency. 1
Guideline-Based Position
Antioxidants as high-dose monotherapy should not be administered without proven deficiency (Grade B recommendation, 96% consensus). 1 This represents the clearest directive from major clinical nutrition guidelines regarding prophylactic high-dose vitamin C use.
Key Distinctions in Vitamin C Recommendations
The evidence distinguishes between three fundamentally different clinical scenarios:
1. Daily Nutritional Requirements (Prevention in Healthy People)
- Ensure adequate daily intake of 100-200 mg/day to maintain optimal immune function 2
- This dose provides saturating plasma levels and optimizes cellular and tissue concentrations 2
- Do not exceed standard dietary reference intakes for infection prevention in well-nourished individuals 1
2. Documented Deficiency States
- Malnourished patients should receive supplementation with vitamins and minerals to maximize anti-infection nutritional defense 1
- Vitamin C deficiency results in impaired immunity and higher susceptibility to infections 2
- Repletion requires 2-3 g/day IV during acute inflammatory states 3
3. Treatment of Established Infections (Not Prevention)
- Treatment of established infections requires significantly higher (gram) doses to compensate for increased inflammatory response and metabolic demand 2
- However, even in sepsis treatment, guidelines recommend against routine vitamin C use 3
Evidence Against Prophylactic High-Dose Use
The belief that extra vitamin C intake can prevent infectious disease in well-nourished populations is not supported by literature. 4 Specifically:
- No studies exist regarding prevention of COVID-19 with high-dose vitamin C supplementation in healthy subjects 4
- Vitamin C does not decrease the average incidence of common colds in the general population 5
- Any effects of supplementation are more prominent when baseline vitamin C levels are low, such as in physically active persons or those with hypovitaminosis 4
Specific Clinical Scenarios Where Vitamin C May Reduce Infection Risk
Physically Active Individuals:
- Vitamin C halved the number of colds in physically active people 5
- This represents the only population where prophylactic benefit has been demonstrated 5
Micronutrient-Deficient Populations:
- Low levels of micronutrients including vitamin C have been associated with adverse clinical outcomes during viral infections 1
- Supplementation is appropriate when deficiency is documented or suspected 1
Safety Considerations and Contraindications
Absolute contraindications to high-dose vitamin C: 3
- Hemochromatosis or iron overload conditions
- G6PD deficiency (risk of hemolysis)
- Renal dysfunction (oxalate stone formation risk)
- History of oxalate kidney stones
Doses exceeding 10 times the dietary reference intake should not be used in clinical settings without proven severe deficiency. 1
Common Pitfalls to Avoid
- Do not recommend high-dose vitamin C for infection prevention in well-nourished individuals - this practice lacks evidence and contradicts guideline recommendations 1, 4
- Do not confuse treatment doses with prevention doses - gram doses are only indicated for established infections with increased metabolic demand, not for prophylaxis 2
- Do not ignore baseline nutritional status - supplementation benefits are limited to those with inadequate baseline intake or increased requirements 4
- Do not measure plasma vitamin C during acute illness - inflammation makes interpretation unreliable 3
Practical Algorithm for Vitamin C and Infection Prevention
Assess nutritional status and risk factors:
For well-nourished, healthy individuals:
For at-risk populations (malnourished, physically active):
For documented deficiency: